Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project

Volume: 43, Issue: 2, Pages: 601 - 612
Published: Oct 27, 2020
Abstract
Background Despite advances in treatments, 30% to 50% of stage III‐IV head and neck squamous cell carcinoma (HNSCC) patients relapse within 2 years after treatment. The Big Data to Decide (BD2Decide) project aimed to build a database for prognostic prediction modeling. Methods Stage III‐IV HNSCC patients with locoregionally advanced HNSCC treated with curative intent (1537) were included. Whole transcriptomics and radiomics analyses were...
Paper Details
Title
Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project
Published Date
Oct 27, 2020
Volume
43
Issue
2
Pages
601 - 612
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.